Hi Sam, I just gave3 your post a "thumbs down"
Post# of 36537
(Total Views: 386)
Posted On: 11/23/2020 9:26:32 AM
Hi Sam,
I just gave3 your post a "thumbs down" rating, as I do not, by any means, agree to or understand your pessimism.
Here is why (one by one response to your made points):
* There are 3 vaccines already at the end of phase III.
True, but fist off they are not yet approved by the FDA, and the FDA may have a different view of the "positive test results" as the companies themselves. Just looking at the way they are calculating their efficiencies, makes me question their anaylses in the general.
Besides, they are all based on a similar technology (RNA, or gene therapy based), and have, as Joe as well as that one SeekingAlpha article pointed out, may likely have serious side effects. In addition, they have even other issues that come with them, like the extremely low temperatures that they need to be stored at (and very little infrastructure already exist throughout the US and the world to support this).
And even if all that can be overcome, it is not as if the Corona virus would disappear just because some people of received a vaccine. These vaccines will give immunity only for a short period of time and thus NGIO's vaccine could still become very useful in the second half of next year, when the first vaccinations, given early next year,may have already lost its immune response.
* We're not even in phase 1 yet!!!
Of course, I would have liked to see much faster progress and especially more relevant status updates about this from the company.
However, firstly, for a long period of time they were simply missing the required funding, which seem to have caused significant delays.
Secondly, they seem to be doing siginificantly more ex-vivo testing in the lab, as everybody else does. So even if they now seem to be significantly behind everybody else in the race, it might only appear like it and they can quickly gain back ground, once the clinical trials have started.
And, besides, in the end the first goal should be to have a save vaccine and not a first one. If that would be the case, why does the world look at Pfizer or Moderna and not the Russian vaccine, which was already released several months ago!?
So I still see a substantial market for NGIO's vaccine, even if that would be available not before the second half of 2021. And obviously so does Bintai Kinden.
I honestly, and generally speaking, do not understand why all your posts are so negative and pessimistic. If you really do think that way, then I only have one suggestion, which I mean in all due respect and seriousness, sell your shares and move on, it is not worth ruining your life from such investments, being constantly frustrated or maybe even so angry or worried that you cannot sleep propperly at night.
So either rethink your attitude or your investment, that is my honest suggestion to you!
I just gave3 your post a "thumbs down" rating, as I do not, by any means, agree to or understand your pessimism.
Here is why (one by one response to your made points):
* There are 3 vaccines already at the end of phase III.
True, but fist off they are not yet approved by the FDA, and the FDA may have a different view of the "positive test results" as the companies themselves. Just looking at the way they are calculating their efficiencies, makes me question their anaylses in the general.
Besides, they are all based on a similar technology (RNA, or gene therapy based), and have, as Joe as well as that one SeekingAlpha article pointed out, may likely have serious side effects. In addition, they have even other issues that come with them, like the extremely low temperatures that they need to be stored at (and very little infrastructure already exist throughout the US and the world to support this).
And even if all that can be overcome, it is not as if the Corona virus would disappear just because some people of received a vaccine. These vaccines will give immunity only for a short period of time and thus NGIO's vaccine could still become very useful in the second half of next year, when the first vaccinations, given early next year,may have already lost its immune response.
* We're not even in phase 1 yet!!!
Of course, I would have liked to see much faster progress and especially more relevant status updates about this from the company.
However, firstly, for a long period of time they were simply missing the required funding, which seem to have caused significant delays.
Secondly, they seem to be doing siginificantly more ex-vivo testing in the lab, as everybody else does. So even if they now seem to be significantly behind everybody else in the race, it might only appear like it and they can quickly gain back ground, once the clinical trials have started.
And, besides, in the end the first goal should be to have a save vaccine and not a first one. If that would be the case, why does the world look at Pfizer or Moderna and not the Russian vaccine, which was already released several months ago!?
So I still see a substantial market for NGIO's vaccine, even if that would be available not before the second half of 2021. And obviously so does Bintai Kinden.
I honestly, and generally speaking, do not understand why all your posts are so negative and pessimistic. If you really do think that way, then I only have one suggestion, which I mean in all due respect and seriousness, sell your shares and move on, it is not worth ruining your life from such investments, being constantly frustrated or maybe even so angry or worried that you cannot sleep propperly at night.
So either rethink your attitude or your investment, that is my honest suggestion to you!
(6)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼